CCCardiol CroatCardiologia CroaticaCardiol. Croat.1848-543X1848-5448Croatian Cardiac SocietyCC 2022 17_9-10_30010.15836/ccar2022.300Extended AbstractAcute coronary syndromesA case study of Impella implementation in the University Hospital Centre Rijeka on a 51-year-old male patient with acute coronary infarctionhttps://orcid.org/0000-0002-3157-1143SaftićLea*https://orcid.org/0000-0002-9496-0680VišnjovskiRužicahttps://orcid.org/0000-0002-1659-1816Bura-NekićDajanahttps://orcid.org/0000-0003-2672-0746KrpanMarijanUniversity Hospital Centre Rijeka, Rijeka, CroatiaADDRESS FOR CORRESPONDENCE: Lea Saftić, Klinički bolnički centar Rijeka, Ul. Tome Strižića 3, HR-51000 Rijeka, Croatia. / Phone: +385-91-300-5602 / E-mail: leasaftic@icloud.com112022179-1030030002112022101120222022Croatian Cardiac SocietyKEYWORDS: Impellaacute myocardial infarctioncardiogenic shock
Acute myocardial infarction is myocardial necrosis caused by interference of the coronary artery. Acute myocardial infarction complicated by cardiogenic shock is quite rare and occurs in only 5-10% of patients who then experience critically decreased myocardial contractility and low cardiac output.
The Impella 2.5 with SmartAssist are temporary ventricular support devices and are used in only high-risk percutaneous coronary interventions (1, 2). This paper presents a case study in which Impella implementation is used as a treatment in an urgent acute myocardial infarction case.
The Impella 2.5 in conjunction with an Automated Impella Controller reported a great result in the treatment of myocardial infarction complicated by cardiogenic shock in a 51-year-old patient at the University Hospital Centre Rijeka.
LITERATUREMøllerJEKjaergaardJTerkelsenCJHassagerC. Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock.J Clin Med. 2022 April 26;11(9):2427. 10.3390/jcm1109242735566553ABIOMED. (2022) Impella 2.5® Smaller access for unloading the left ventricle. Available at: https://www.heartrecovery.com/products-and-services/impella/impella-25